Laboratory:Akiruno
- TOP
- gene-related test
- genetic tests for malignant tumor (solid tumor)
- Thyroid Cancer Oncomine DxTT Multi-2 Gene CDxFFPE
Laboratory:Akiruno
○Thyroid Cancer Oncomine DxTT Multi-2 Gene CDxFFPE
CODE:00W53 0
-
TEST NAME
SPECIMEN
REQUIREMENT
(mL) CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT) -
Thyroid Cancer Oncomine DxTT Multi-2 Gene CDxFFPE
Unstained specimen slide
5 to 10 sheets
thickness 5μm
Z10
6-11 Next Generation Sequencing (NGS)A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments.
COMMENT
The purpose of this test is to analyze RET fusion gene, RET gene mutation, BRAF gene V600E mutation in genomic DNA and RNA extracted from cancer tissue, and to assist in determining the indications for the drugs listed separately for thyroid cancer and medullary thyroid cancer..
The percentage of tumor cells required for the test is at least 30%.
See below for notes on the submission of unstained specimen slides.
Avoid duplicate requests in one sample. Since contamination has a greater effect on this test method, handle specimens with care when collecting them.
When requesting this test, ensure to also request the nucleic acid extraction item (item code: M9514)
●About submission of unstained specimen slides
Immediately immerse the collected tissue in a 10% neutral buffered formalin solution and fix it (recommended fixation time is 6 to 48 hours). For submission, please prepare 5-μm-thick serial sections from formalin-fixed, paraffin-embedded tissue blocks.For submission, please prepare 5-μm-thick serial sections from formalin-fixed, paraffin-embedded tissue blocks. Be careful to avoid contamination by changing the microtome blade for each specimen when slicing. Note that as nucleic acids are fragmented due to formalin fixation of tissues, analysis may not be possible depending on the type and composition of the fixative, fixation time, and storage condition of the specimen after fixation.
CONTAINER
Z10 旧容器記号 t 30
[オブジェクトケース]
プレパラート (スライドグラス)
貯蔵方法:室温
supplementary information
対象遺伝子変異等と関連する医薬品および適応がん腫
遺伝子変異等 | がん腫 | 関連する医薬品 |
---|---|---|
RET融合遺伝子 | 甲状腺癌 | セルペルカチニブ |
BRAF遺伝子V600E変異 | エンコラフェニブ及びビニメチニブ | |
RET遺伝子変異 | 甲状腺髄様癌 | セルペルカチニブ |